Literature DB >> 8404659

A polyclonal antibody to a synthetic peptide derived from the rat follicle-stimulating hormone receptor reveals the recombinant receptor as a 74-kilodalton protein.

J Quintana1, R W Hipkin, M Ascoli.   

Abstract

We have prepared a polyclonal antibody (AntiF) against a synthetic peptide comprising residues 19-29 of the rat FSH receptor. The specificity of this antibody was documented using human embryonic kidney (293) cells and stable transfectants of 293 cells expressing the recombinant LH/CG and FSH receptors. The data presented show that AntiF inhibits the binding of FSH, but not that of LH/CG, to their cognate receptors. AntiF also recognizes a specific protein(s) representing the FSH receptor in Western blots or by immunoprecipitation of cells transfected with the FSH receptor. This protein(s) is not present in untransfected 293 cells or in 293 cells permanently transfected with the LH/CG receptor. Finally, addition of the 19-29 peptide prevents immunoprecipitation of the FSH receptor by AntiF, whereas an unrelated peptide corresponding to residues 637-647 has no effect. In Western blots of 293 cells transfected with the FSH receptor, AntiF reveals the recombinant receptor as a heterogenous glycoprotein with a molecular mass of 58,000-83,000 daltons (in the absence of thiol-reducing agents) or 69,000-81,000 (in the presence of thiol reducing agents). Pulse-chase experiments with metabolically labeled cells show that the mature FSH receptor is a 74-kilodalton protein derived from 67- and 72-kilodalton precursors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404659     DOI: 10.1210/endo.133.5.8404659

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation.

Authors:  Colette Galet; Mario Ascoli
Journal:  Mol Endocrinol       Date:  2006-06-27

2.  Extragonadal FSH receptor: is it real?

Authors:  T Rajendra Kumar
Journal:  Biol Reprod       Date:  2014-08-20       Impact factor: 4.285

3.  A follicle-stimulating hormone receptor ecto-domain epitope that is a target for receptor immunoneutralization yet does not affect ligand contact and activation.

Authors:  X Liu; G M Butterstein; B Lindau-Shepard; H A Brumberg; J A Dia
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 4.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

5.  FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice.

Authors:  Julie A W Stilley; Debora E Christensen; Kristin B Dahlem; Rongbin Guan; Donna A Santillan; Sarah K England; Ayman Al-Hendy; Patricia A Kirby; Deborah L Segaloff
Journal:  Biol Reprod       Date:  2014-08-06       Impact factor: 4.285

6.  Naturally Occurring Follicle-Stimulating Hormone Glycosylation Variants.

Authors:  John S Davis; T Rajendra Kumar; Jeffrey V May; George R Bousfield
Journal:  J Glycomics Lipidomics       Date:  2014

7.  Differential Regulation of Human and Mouse Myometrial Contractile Activity by FSH as a Function of FSH Receptor Density.

Authors:  Julie A W Stilley; Rongbin Guan; Donna A Santillan; Bryan F Mitchell; Kathryn G Lamping; Deborah L Segaloff
Journal:  Biol Reprod       Date:  2016-06-22       Impact factor: 4.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.